The APOE Gene and Differences in Life Expectancy in Europe

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 59, Issue 1, 2004, Pages 16-20

  Ewbank, Douglas C ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Population Studies Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

AGE; AGED; ALZHEIMER DISEASE; ARTICLE; CHRONIC DISEASE; DENMARK; DISEASE ASSOCIATION; EUROPE; FEMALE; FINLAND; FRANCE; GENDER; GENE FREQUENCY; GENOTYPE; HEREDITY; HUMAN; ISCHEMIC HEART DISEASE; ITALY; LIFE EXPECTANCY; LIFESPAN; MALE; MORTALITY; NETHERLANDS; PRIORITY JOURNAL; RISK; STANDARDIZATION; SWEDEN;

EID: 0347269084     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/59.1.b16     Document Type: Article

References (43)

1. Heijmans BT, Westendorp RG, Slagboom PE. Common gene variants, mortality and extreme longevity in humans. Exp Gerontol. 2000:35:865-877.
2. Fullerton SM, Clark AG, Weiss KM, et al. Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. Am J Hum Genet. 2000;67:881-900.
3. Nickerson DA, Taylor SL, Fullerton SM, et al. Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene. Genome Res. 2000;10:1532-1545.
4. Stengard JH, Clark AG, Weiss KM, et al. Contributions of 18 additional DNA sequence variations in the gene encoding apolipoprotein E to explaining variation in quantitative measures of lipid metabolism. Am J Hum Genet. 2002;71:501-517.
5. Ewbank DC. Demography in the age of genomics: a first look at the prospects. In: Finch CE, Vaupel JW, Kinsella K, ed. Cells and Surveys: Should Biological Measures Be Included in Social Science Research? Washington, DC: National Academy Press; 2000:64-109.
6. Wilson PW, Myers RH, Larson MG, Ordovas JM, Woll PA, Schaefer EJ. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA. 1994;272:1666-1671.
7. Orchard TJ, Eichner J, Kuller LH, Becker DJ, McCallum LM, Grandits GA. Insulin as a predictor of coronary heart disease: interaction with apolipoprotein e phenotype. A report from the multiple risk factor intervention trial. Ann Epidemiol. 1994;4:40-45.
8. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. JAMA. 1997;278:1349-1356.
9. Corder EH, Saunders AM, Striumayer WJ, et al. Gene doses of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921-923.
10. Skoog I, Hesse C, Aevarsson O, et al. A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality. J Neurol Neurosurg Psychiatry. 1998;64:37-43.
11. Smith JD. Apolipoprotein E4: an Allele Associated With Many Diseases. Ann Med. 2000;32:118-127.
12. Valdez R, Howard BV, Stern MP, Haffner SM. Apolipoprotein e polymorphism and insulin levels in a biethnic population [Abstract]. Diabetes Care. 1995;18:992-1000.
13. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC. Apolipoprotein E Polymorphism and Cardiovascular Disease: a Huge Review. Am J Epidemiol. 2002;155:487-495.
14. Gerdes LU, Gerdes C, Hansen PS, Klausen IC, Faergeman O, Dyerberg J. The apolipoprotein E polymorphism in Greenland Inuit in its global perspective. Hum Genet. 1996;98:546-550.
15. Corbo RM, Scacchi R. Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 "thrifty" allele? Ann Hum Genet. 1999;63(Pt 4):301-310.
16. Rothman KJ, Greenland S. Modern Epidemiology. Philadelphia: Lippincott-Raven; 1998.
17. Ewbank DC. Mortality differences by APOE genotype estimated from demographic synthesis. Genet Epidemiol. 2002;22:146-155.
18. Vogt MT, Cauley JA, Kuller LH. Apolipoprotein e phenotype, arterial disease, and mortality among older women: the Study of Osteoporotic Fractures. Genet Epidemiol. 1997;14:147-156.
19. Aevarsson O, Svanborg A, Skoog I. Seven-year survival rate after age 85 years: relation to Alzheimer disease and vascular dementia. Arch Neurol. 1998;55:1226-1232.
20. Tilvis RS, Strandberg TE, Juva K. Apolipoprotein E phenotypes, dementia and mortality in a prospective population sample. J Am Geriatr Soc. 1998;46:712-715.
21. Lee JH, Tang M-X, Schupf N, et al. Mortality and apolipoprotein E in Hispanic, African-American, and Caucasian elders. Am J Med Genet. 2001;103:121-127.
22. Fillenbaum GG, Blazer DG, Burchett BM, Saunders AM, Taylor DH Jr. Apolipoprotein E ε4 and risk of mortality in African American and while older community residents. Gerontologist. 2002;42:381-386.
23. Juva K, Verkkoniemi A, Viramo P, et al. APOE epsilon4 does not predict mortality, cognitive decline, or dementia in the oldest old. Neurology. 2000;54:412-415.
24. Gerdes LU, Jeune B, Ranberg KA, Nybo H, Vaupel JW. Estimation of apolipoprotein E genotype-specific relative mortality risks from the distribution of genotypes in centenarians and middle-aged men: apolipoprotein E gene is a "frailty gene," not a "longevity gene." Genet Epidemiol. 2000;19:202-210.
25. Schächter F, Faure-Delanef L, Guenot FG, et al. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet. 1994;6:29-32.
26. Kervinen K, Savolainen MJ, Salokannel J, et al. Apolipoprotein E and B polymorphisms-longevity factors assessed in nonagenarians. Atherosclerosis. 1994;105:89-95.
27. Frisoni GB, Louhija J, Geroldi C, Trabucchi M. Longevity and the ε2 allele of apolipoprotein E: the Finnish Centenarians Study. J Gerontol Med Sci. 2001;56A:M75-M78.
28. Panza F, Solfrizzi V, Torres F, et al. Decreased frequency of apolipoprotein E ε4 allele from Northern to Southern Europe in Alzheimer's disease patients and centenarians. Neurosci Lett. 1999;277:53-56.
29. Corder EH, Lannfelt L, Viitanen M, et al. Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition. Arch Neurol. 1996;53:418-422.
30. Lambert J-C, Pasquier F, Cottel D, Frigard B, Amouyel P, Chartier-Harlin M-C. A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's Disease. Hum Mol Genet. 1998:7:533-540.
31. Lehtimäki T, Moilanen T, Viikari J, et al. Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study. J Lipid Res. 1990;31:487-495.
32. Ehnholm C, Lukka M, Kuusi T, Nikkilä E, Utennann G. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res. 1986;27:227-235.
33. Eggertsen G, Tegelman R, Ericsson S, Angelin B, Berglund L. Apolipoprotein E polymorphism in a healthy Swedish population: variation of alleles frequency with age and relation to serum lipid concentrations. Clin Chem. 1993;39:2125-2129.
34. Feskens EJ, Havekes LM, Kalmijn S, de Knijff P, Launer LJ, Kromhout D. Apolipoprotein e4 allele and cognitive decline in elderly men. Br Med J. 1994;309:1202-1206.
35. Heijmans BT, Westendorp RGJ, Knook DL, Kluft C, Slagboom PE. The risk of mortality and the factor V Leiden mutation in a population-based cohort. Thromb Haemost. 1998;80:607-609.
36. James RW, Boemi M, Giansanti R, Fumelli P, Pometta D. Underexpression of the apolipoprotein e4 isoform in an Italian population. Arterioscler Thromb. 1993;13:1456-1459.
37. Bailleul S, Couderc R, Landais V, Lefevre G, Raichvarg D, Etienne J. Direct phenotyping of human apolipoprotein E in plasma: application to population frequency distribution in Paris (France). Hum Hered. 1993;43:159-165.
38. Klasen EC, Smit M, de Kniff P, Gevers Leuven J, Kempen-Voogd R, Havekes L. Apolipoprotein E phenotype and gene distribution in The Netherlands. Hum Hered. 1987;37:340-344.
39. Gerdes LU, Klausen IC, Sihm I, Færgeman O. Apolipoprotein E Polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet Epidemiol. 1992;9:155-167.
40. Lucotte G, Loirat F, Hazout S. Pattern of gradient of apolipoprotein E allele ε4 frequencies in Western Europe. Hum Biol. 1997;69:253-262.
41. Human Mortality Database. Accessed October 12, 2002. Web Page. Available at: www.mortality.org or www.humanmortality.de
42. Herskind AM, McGue M, Holm NV, Sörensen TIA, Harvald B, Vaupel JW. The heritability of human longevity: a population-based study of 2872 Danish twin pairs born 1870-1900. Hum Genet. 1996;97:319-323.
43. Hendrie HC, Osuntokun BO, Hall KS, et al. Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans. Am J Psychiatry. 1995;152:1485-1489.